T he atlantoaxial spine is a complex region with distinctive anatomy that differentiates it from the remainder of the spine. 1 Fusion surgeries of this region exhibit a unique set of surgical indications, techniques, and complications. [1] [2] [3] [4] For instance, such fusions may be performed in the setting of odontoid fracture, basilar invagination or atlantoaxial instability due to rheumatoid disease, and neoplasm of the atlantoaxial region. 4 Modern instrumentation methods include transarticular screws and screw-rod constructs. Fixation for the latter typically involves lateral mass screws in C1 and pars interarticularis or pedicle screws in C2. 3 Given the complex anatomy of the region, these procedures may be complicated by injury to the vertebral arteries, nerve roots, and dura. Currently, there is a paucity of large-scale studies focused on atlantoaxial fusion, as the existing literature on cervical spine procedures has not provided detailed reports on this unique region. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] This study of a large state-wide database was undertaken to describe the epidemiology and complications of as well as indications for primary atlantoaxial fusion.
MATERIALS AND METHODS
The New York Department of Health's Statewide Planning and Research Cooperative System (SPARCS) database, established in 1979, is an all-payer data reporting system that collects patient-level information on demographics, diagnoses, and treatments for all surgeries performed in nonfederal facilities the state of New York. 17 Annual reports from SPARCS indicate that data completeness during the years 1997 through 2011 ranged from 95% to 100% with a median value of 99%. 18 The 2012 completeness report was not yet available at the time of manuscript submission. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis and procedural codes are used for categorization of inpatient data in SPARCS.
The SPARCS database was queried to identify all adult patients undergoing primary isolated atlantoaxial fusion in the 16 years spanning from 1997 through 2012 using ICD-9-CM procedure code 81.01. In an effort to focus specifically on C1-C2 pathology, patients undergoing concurrent fusion of other spinal levels (ICD-9-CM 81.00, 81.02-81.08, 81.30, 81.32-81.38) were excluded. Any atlantoaxial fusion surgeries (ICD-9-CM 81.01, 81.31) following the index procedure were also excluded. Patients with missing patient identifiers and nonresidents of New York State were also excluded. Bone morphogenetic protein (BMP) utilization was determined using ICD-9-CM code 84.52, which was first introduced in October 2002. In order to allow time for widespread adoption of the new code, it is reported here beginning in the year 2004 and continuing through the remainder of the study period.
Demographic (age, gender, race/ethnicity, and insurance status) and clinical [Charlson/Deyo and Elixhauser comorbidity measures, in-hospital surgical complications and mortality, length of stay (LOS), and discharge disposition] data for patients meeting inclusion and exclusion criteria were then extracted from the database. The Charlson/Deyo Comorbidity Index (CDCI) was then calculated; this modification of the original Charlson Comorbidity Index uses 17 categories of comorbid illness to predict 10-year mortality. 19, 20 The Elixhauser measures are a set of comorbidities that are associated with poor hospital outcomes and can be identified in large administrative inpatient datasets based on ICD-9-CM diagnosis codes. 21 Primary diagnosis codes as well as the diagnoses present on admission (based on Present on Admission coding) were used to identify conditions that likely contributed to the need for atlantoaxial fusion. For each patient, all applicable conditions were considered surgical indications. Tables containing the specific codes used to define surgical indications and complications are provided in the supplementary Appendix section, http://links.lww.com/BRS/B145.
United States Census Bureau intercensal estimates from 1997 through 2012 for New York State were used to calculate atlantoaxial fusion rates per 100,000 population.
Statistical significance was set at P < 0.05, and 95% confidence intervals (CIs) were reported wherever applicable. Linear regression was used for time trend analysis.
RESULTS
During the 16-year study period, 1559 patients underwent isolated primary atlantoaxial fusion in the state of New York. Six of these patients lacked a patient identifier in the dataset and were excluded from analysis. The annual volume was 103 in 1997 and 118 in 2012. Once adjusted for population growth, the surgical rates were 0.74 per 100,000 population (95% CI, 0.59-0.88) in 1997 and 0.77 per 100,000 population (95% CI, 0.63-0.91) in 2012 ( Figure 1 ). This increase did not represent a statistically significant trend (regression coefficient 0.005, P ¼ 0.341).
Demographics and comorbidities of the study population are presented in Table 1 . The mean age at surgery was 60.2 AE 18.3 years. There was a modest but statistically significant upward trend in the population-adjusted surgical rate in individuals aged 70 years and older (regression coefficient 0.051, P ¼ 0.023) ( Figure 2 ). However, linear regression revealed no significant trend for the remainder of the age groups. By 2012, older age groups tended to exhibit higher surgical rates. The cohort of individuals aged 70 years and older had a significantly higher incidence of atlantoaxial fusion surgery (2.37 per 100,000 population; 95% CI, 1.68-3.07) than any other group. The 18 to 34 years cohort had the lowest rate (0.27 per 100,000 population; 95% CI, 0.12-0.42); this reached statistical significance when compared against all except the 35 to 49 age group (0.55 per 100,000 population; 95% CI, 0.32-0.79). Approximately 85% of patients had a CDCI of zero or one.
Surgical indications for isolated primary atlantoaxial fusion are listed in Table 2 . Subgroup analysis revealed that the percentage of cases performed for rheumatic disease declined over time (regression coefficient À0.68, P ¼ 0.002), and the percentage performed to address fractures increased (regression coefficient 1.05, P ¼ 0.014) ( Figure 3 ). No significant changes in relative utilization were observed over the study period for the remainder of the five most common surgical indications (i.e., degenerative disc disease, malunion/nonunion, spondylosis). By 2012, surgical management of fractures was the most common indication for atlantoaxial fusion (44.1%; 95% CI, 32.1-56.1); this relationship demonstrated statistical significance. The second most common indication was degenerative disc disease (21.2%; 95% CI, 12.9-29.5), which was more common than malunion/nonunion (6.8%; 95% CI, 2.9-11.5) but did not differ significantly from spondylosis (13.6%; 95% CI 6.9-20.2) or rheumatic disease (9.3%; 95% CI, 3.8-14.8).
Utilization of BMP remained fairly constant over time: it was used in 7.6% of cases (95% CI, 2.4-13.0) in 2004 and 11.0% of cases (95% CI, 5.0-17.0) in 2012 ( Figure 4 ). Linear regression revealed no significant overall trend (regression coefficient À0.09, P ¼ 0.835). Review of the data suggested that there was an increasing use from 2004 to 2008, followed by a rapid decline. However, none of the individual data points differed significantly from any of the others, which precluded the ability to draw concrete conclusions.
In-hospital complications and mortality, LOS, and discharge disposition are detailed in Table 3 . Overall, there were 167 inpatient complications in the 1559 procedures. Dysphagia or dysphonia occurred after 0.8% of cases, dural tear during 0.3%, infection after 0.5%, and seroma, hematoma, or hemorrhage after 0.5%. The most common medical complications were respiratory complications (observed after 5.4% of operations) and sepsis and/or shock (observed after 2.1% of operations). LOS averaged 11.2 AE 18.4 days, with 59.6% of patients being discharged home, 15.3% going to a skilled nursing facility, 11.7% going to an inpatient rehabilitation center, and 2.7% dying before discharge. Seventy-six percent of in-hospital mortalities occurred in patients who had fracture as their initial surgical indication.
DISCUSSION
The analyses presented above suggest that isolated primary atlantoaxial fusions are fairly uncommon procedures with stable utilization rates over the past 16 years in the state of New York. Nonetheless, they are associated with in-house mortality rates of 2.7% despite the fact that a large majority of these patients are relatively healthy before surgery. The existing epidemiologic literature on atlantoaxial fusions is limited. A single paper has detailed the frequency with which this procedure is performed in the United States (US) population. 10 Stein et al. 10 analyzed data from the National Inpatient Sample (NIS) and identified a total of 36,200 primary (but not necessarily isolated) atlantoaxial fusions in the years 1992 to 2008. They determined that the incidence of atlantoaxial fusion increased from 0.53 to 1.03 cases per 100,000 general population over their study period. In patients with rheumatoid arthritis (RA), however, it decreased from 0.13 to 0.09 cases per 100,000 general population over the same timeframe, likely as a result of the increased utilization of disease-modifying anti-rheumatic drugs. Both of these findings were statistically significant. Comparison of these data with that presented herein reveals that approximately 4% of the atlantoaxial fusions in the US each year are performed in New York State. Although both analyses suggest that RA is becoming less of a driver for atlantoaxial fusion volume, they contrast in their findings regarding trends in the general population. This discrepancy may be attributable to differences between surgical decisionmaking or patient populations between New York and the remainder of the country; differences in data collection and recording between the datasets; or the inclusion of nonisolated atlantoaxial fusions in the NIS study.
Elliott et al. 3 performed a meta-analysis of articles pertaining to atlantoaxial fusions. They identified papers describing 3146 such cases, 95.8% of which were isolated C1-C2 fusions. Average patient age at the time of surgery was 48.8 years. Operative indications included fracture (28.1%), RA (35.1%), and osteoarthritis (2%). Notable complications were infection (1.3%), vascular injury (0.9%), dural tear (0.2%), and dysphagia (0.1%). Perioperative mortality was rate was 0.7%. Their findings differ most notably from those presented here with respect to operative indications-this is likely due to the fact that the meta-analysis included publications dating back as far as 1991, when medical management of RA was less sophisticated. In addition, their average patient age was over a decade lower than that of the patients presented here.
As a point of comparison, large-scale, database-derived analyses of subaxial spinal fusions have demonstrated a steady increase in the volume of such procedures over time. 9, [12] [13] [14] 16 Calculations based on the work of Oglesby et al. 13 reveal that approximately 170,000 subaxial fusions were performed in the US in 2009, for a population-adjusted incidence of 55.2 cases per 100,000 population. This was approximately 80 times the rate of atlantoaxial fusion in New York in the same year. Published perioperative complication rates for subaxial fusion have ranged from 2.6% to 17.4%, 6, 7, 16 and reported in-hospital mortality rates have been between 0.4% and 5.7%. 7, 9, 13, 15, 16 While these findings are similar to those observed for the atlantoaxial region in this study, published LOS values have been markedly shorter for subaxial fusions (1.6-4.0 vs. 11.2 d). 6, 7, 9, 13, 15, 16 Trends in BMP utilization in the subaxial spine appear to have mirrored those observed in the atlantoaxial region, with increasing use until around 2008, followed by a sharp decline. 5, 8, 9 Although the above studies employed different databases (MarketScan, NIS, and Medicare Claims and Enrollment data) and demonstrate variability in their methodology, they provide a reference against which to compare atlantoaxial fusion.
Population-based database research has inherent limitations. The quality of the ultimate analysis is contingent on the rigor of the initial administrative coding. For instance, due to an idiosyncrasy of the SPARCS database, patients suffering from AIDS were not assigned patient identifiers. The six patients excluded from the study cohort all fell into this group. It is also conceivable that complications may be inconsistently reported (especially if their presence did not impact reimbursement). A recent comparison of two large national databases, for example, found that groups of demographically similar lumbar spine fusion patients had significantly different recorded comorbidity profiles and adverse inpatient event rates. 22 In addition, ICD-9-CM administrative data lack the granularity to make some clinical distinctions: surgical approach and fusion technique are not specified by the current codes and could therefore not be parsed out in this analysis; diagnosis codes are not directly linked to procedure codes, which imparts ambiguity on the task of assigning surgical indications; and, in a relatively small percentage of cases, these diagnosis codes were not sufficiently specific to ascribe any meaningful indication to a procedure. Because of the lack of sufficiently nuanced data, authors are unable to provide specific treatment recommendations.
The SPARCS database is limited to the state of New York, which may diminish investigators' ability to obtain statistically significant findings regarding unusual procedures. Temporal trends in BMP use for atlantoaxial fusion, for instance, may have reached statistical significance given a larger population size. However, SPARCS offers some unique capabilities that set it apart from other large data sets. It is a complete database that includes nearly 100% of the surgeries performed in its target population annually. This stands in contrast to the MarketScan and NIS databases that contain only a subset of operations performed-NIS only includes 20% of hospital discharges, and MarketScan is a convenience sample. 8, 23 These characteristics have the potential to introduce sampling bias. Meanwhile, Medicare data have limited generalizability to the overall population, as only patients aged 65 years and older are included. Furthermore, unlike the NIS, the SPARCS dataset includes unique patient identifiers that allow individuals to be tracked over time. This allowed for exclusion of procedures that were erroneously coded as primary atlantoaxial fusions despite the presence of prior C1-C2 fusions during the study period.
In conclusion, isolated primary atlantoaxial fusions are relatively uncommon and not growing in frequency in New York State. If these findings are generalizable to the remainder of the country, the number of such procedures performed nationwide would be expected to have also remained stable. Despite the fact that a large majority of these patients are relatively healthy before surgery (CDCI zero or one), their average LOS is over 11 days, approximately one in 10 experiences an in-hospital complication, and nearly 3% die while in house. Knowledge of these risks will hopefully facilitate further efforts to minimize them and allow for more accurate pre-operative counseling of patients and their families.
Key Points
The overall population-adjusted annual rate of atlantoaxial fusions did not change significantly over the 16-year period from 1997 through 2012. Over time, a significantly lower proportion of atlantoaxial fusions were attributable to rheumatic disease. By the end of the study period, management of fractures was the most common indication for C1-C2 fusion (44.1% of cases). In-hospital mortality was 2.7%, of which 76% had fracture as the surgical indication.
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